POTENTIAL USAGE OF NK CELLS AND NKG2D-POSITIVE LYMPHOCYTES AS TARGETS IN THERAPY OF CROHN’S DISEASE

Código QR

POTENTIAL USAGE OF NK CELLS AND NKG2D-POSITIVE LYMPHOCYTES AS TARGETS IN THERAPY OF CROHN’S DISEASE

Autoimmune mechanisms of Crohn’s disease have been extensively studied, following discovery of NOD2, ATG16L1, IRGM genetic polymorphisms associated with Crohn’s disease. These genes play an important role in innate immune response against intracellular bacteria, in particular, due to the...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	E. A. Shulenina, E. V. Abakushina, E. Yu. Lyssuk
Formato:	article
Lenguaje:	RU
Publicado:	SPb RAACI 2017
Materias:	nkg2d nk mica macrophages autoimmunity crohn’s disease Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/14b35839d7d04147936c7ec1e475d759
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

INHIBITION OF THE NKG2D ACTIVATING RECEPTOR EXPRESSION ON CYTOTOXIC LYMPHOCYTES BY RECOMBINANT MICA PROTEIN
por: E. V. Abakushina, et al.
Publicado: (2017)

TUMOR-SPECIFIC IMMUNE RESPONSE AFTER PHOTODYNAMIC THERAPY
por: Yu. N. Anokhin, et al.
Publicado: (2016)

CIRCULATING MICA PROTEIN IN PATIENTS WITH MALIGNANT LYMPHOMAS
por: A. V. Klinkova, et al.
Publicado: (2016)

DISTRIBUTION OF <i>MICA</i> ALLELES IN THE RUSSIAN POPULATION
por: L. M. Kanevskiy, et al.
Publicado: (2019)

piggyBac system to co-express NKG2D CAR and IL-15 to augment the in vivo persistence and anti-AML activity of human peripheral blood NK cells
por: Zhicheng Du, et al.
Publicado: (2021)

Current Perspectives on “Off-The-Shelf” Allogeneic NK and CAR-NK Cell Therapies
por: Erica L. Heipertz, et al.
Publicado: (2021)

Selinexor Enhances NK Cell Activation Against Malignant B Cells via Downregulation of HLA-E
por: Jack G. Fisher, et al.
Publicado: (2021)

Effectiveness of Crohn’s Disease Exclusion Diet for Induction of Remission in Crohn’s Disease Adult Patients
por: Martyna Szczubełek, et al.
Publicado: (2021)

PECULIARITIES OF NK CELLS DIFFERENTIATION: CD56dim AND CD56bright NK CELLS AT PREGNANCY AND IN NON-PREGNANT STATE
por: V. A. Mikhailova, et al.
Publicado: (2017)

Crohn’s Disease Ocular Manifestations
por: Koev Kr.
Publicado: (2014)

Current Overview on the Use of Mesenchymal Stem Cells for Perianal Fistula Treatment in Patients with Crohn’s Disease
por: Marcin Włodarczyk, et al.
Publicado: (2021)

Surgery for Crohn’s Disease Affects Male Sexual Function
por: Kelly Scarberry, et al.
Publicado: (2019)

Colitis de Crohn: resultados del tratamiento quirúrgico y evolución alejada
por: Imigo G.,Felipe, et al.
Publicado: (2018)

Mycobacterium avium subsp paratuberculosis y enfermedad de Crohn: evidencias de una zoonosis
por: Retamal M,Patricio, et al.
Publicado: (2011)

HETEROGENEITY OF NK AND NKT LYMPHOCYTE POPULATIONS IN HEALTHY DONORS
por: D V. Tabakov, et al.
Publicado: (2017)

Mucosal Healing in Crohn’s Disease: Bull’s Eye or Bust? The “Relative” Con Position
por: Mahmoud Mosli, et al.
Publicado: (2021)

Mucosal Healing in Crohn’s Disease: Bull’s Eye or Bust? “The Pro Position”
por: Neil O’Moráin, et al.
Publicado: (2021)

Chitosan nanoparticle-based delivery of fused NKG2D–IL-21 gene suppresses colon cancer growth in mice
por: Tan L, et al.
Publicado: (2017)

Estrés oxidativo, prooxidantes y enfermedad de Crohn
por: Tapia S,Alexis, et al.
Publicado: (2006)

Extraintestinal Manifestations and Intestinal Complications in Patients with Crohn's Disease: Associations with Some Clinico-Laboratory Findings, Immunological Markers and Therapy
por: Velikova Tsvetelina, et al.
Publicado: (2018)

EVALUATION OF MICROVESICLES FORMED BY NATURAL KILLER (NK) CELLS USING FLOW CYTOMETRY
por: V. A. Mikhailova, et al.
Publicado: (2018)

Diverticulitis aguda de intestino delgado en un paciente con enfermedad de Crohn: Report of one case
por: Hevia,Macarena, et al.
Publicado: (2017)

Experiencia local con natalizumab en pacientes con enfermedad de Crohn refractaria a anti-TNF: Casos clínicos
por: Fluxá,Daniela, et al.
Publicado: (2017)

Difficulties in the differential diagnosis of intestinal tuberculosis and Crohn‘s disease
por: M. N. Reshetnikov, et al.
Publicado: (2021)

DIFFERENTIATION OF NK CELLS. A LOOK THROUGH THE PRISM OF TRANSCRIPTION FACTORS AND INTRACELLULAR MESSENGERS
por: V. A. Mikhailova, et al.
Publicado: (2019)

Mesotelioma benigno como causa de dolor abdominal inespecífico en un paciente con Enfermedad de Crohn
por: Fluxá,Daniela, et al.
Publicado: (2016)

Chronic Recurrent Multifocal Osteomyelitis Associated with Crohn Disease: A Potential Role of Exclusion Diet? Comment on Starz et al. The Modification of the Gut Microbiota via Selected Specific Diets in Patients with Crohn’s Disease. <i>Nutrients</i> 2021, <i>13</i>, 2125
por: Erika Cantarelli, et al.
Publicado: (2021)

An alternative splicing signature in human Crohn’s disease
por: Daowei Li, et al.
Publicado: (2021)

Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
por: Sergey Kulemzin, et al.
Publicado: (2021)

Linfoma T/NK extraganglionar tipo nasal: Caso clínico
por: Alvarez N,Candelas, et al.
Publicado: (2017)

Infliximab en el tratamiento de la enfermedad de Crohn: Estudio preliminar
por: Gellona V,José, et al.
Publicado: (2006)

CHARACTERISTICS OF SIGNALING PATHWAYS MEDIATING A CYTOTOXIC EFFECT OF DENDRITIC CELLS UPON ACTIVATED Т LYMPHOCYTES AND NK CELLS
por: T. V. Tyrinova, et al.
Publicado: (2014)

PATTERNS OF REGULATORY T-CELLS AND NK-CELLS LEVELS IN PATIENTS WITH HEPATITIS C VIRUS INFECTION
por: M. S. Selkova, et al.
Publicado: (2014)

Selective biologics for ulcerative colitis and Crohn's disease – clinical utility of vedolizumab
por: Petkau JM, et al.
Publicado: (2016)

Clinical utility of ustekinumab in Crohn’s disease
por: Kotze PG, et al.
Publicado: (2018)

Crohn's disease with pathological findings of a granulomatous lesion in the appendix
por: Naoya Sakamoto, et al.
Publicado: (2022)

Nephrotic syndrome after treatment of Crohn′s disease with mesalamine: Case report and literature review
por: Belal M Firwana, et al.
Publicado: (2012)

FEATURES OF NK-CELL CONTENTS IN PATIENTS WITH CHRONIC HEPATITIS C
por: M. S. Selkova, et al.
Publicado: (2014)

Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells
por: Fabio Guolo, et al.
Publicado: (2021)

Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn’s disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience
por: Alvisi P, et al.
Publicado: (2019)